17 results
8-K
EX-10.1
ADPT
Adaptive Biotechnologies Corp
12 Sep 22
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million
8:45am
, reexamination proceeding, cancellation proceeding, injunction, lawsuit, declaratory judgment, administrative post-grant review proceeding, other
10-K
2019 FY
ADPT
Adaptive Biotechnologies Corp
26 Feb 20
Annual report
4:53pm
, could increase our insurance rates or prevent us from securing insurance coverage in the future. Additionally, any product liability lawsuit could … of any lawsuit or failure to obtain any of these licenses could prevent us from commercializing products or services, and the prohibition of sale of any
424B4
blwh2u
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
r2gebu6co0h8
9 Jan 20
Draft registration statement
12:00am
424B4
9a1 i29pn
27 Jun 19
Prospectus supplement with pricing info
5:24pm
S-1
20ikjzbfxtq9haqsj
30 May 19
IPO registration
5:20pm
S-1
EX-10.2
eusd8
30 May 19
IPO registration
5:20pm
DRS/A
8x74w1x051fihvl802s0
8 May 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.2
0mwktwy 2t4bsjsoa
8 May 19
Draft registration statement (amended)
12:00am
DRS
0tyutvd
29 Mar 19
Draft registration statement
12:00am
- Prev
- 1
- Next